Multiple reputable sources, including Reuters and CNBC, report that Akeso's experimental lung cancer drug, ivonescimab, has demonstrated significant efficacy in a late-stage clinical trial in China. The drug improved overall survival for lung cancer patients, reducing the risk of death by 34% and extending patient lifespans by 15% compared to a leading immunotherapy. These results, presented at a major oncology meeting, are supported by consistent trial data across several outlets, indicating a potentially important advancement in the treatment of lung cancer. The findings highlight the ongoing progress in oncology drug development and the potential for new therapies to outperform existing standards of care.
In addition to Akeso's breakthrough, Johnson & Johnson's prostate cancer drug Erleada has also shown promising results in a late-stage trial. When used in combination with hormone-blocking therapy before and after surgery, Erleada reduced the risk of cancer spread and death, according to data presented at a medical conference. Multiple mainstream sources confirm the consistency of these trial endpoints, underscoring the drug's potential to improve outcomes for prostate cancer patients. These developments reflect a broader trend of innovation and progress in cancer therapeutics, offering hope for improved survival rates and quality of life for patients facing serious diagnoses.
Meanwhile, the S&P 500 dividend yield has dropped to 1.08%, marking the lowest payout rate since the 1800s. This historic low, corroborated by 24/7 Wall Street and supported by historical financial data, signals a shift in the income landscape for equity investors. As companies prioritize growth and share buybacks over dividend distributions, investors seeking yield may need to reassess their strategies or look to alternative asset classes to meet their income needs in the current market environment.
🔹
Justification: The news highlights major breakthroughs in oncology drug development, with both Akeso and Johnson & Johnson reporting strong, late-stage clinical trial results for cancer therapies. These advances are likely to boost sentiment in the healthcare and biotech sectors, reflecting significant progress and potential for improved patient outcomes. However, the historic drop in the S&P 500 dividend yield introduces a mild negative for income-focused investors, signaling a shift in market dynamics. On balance, the positive impact from medical innovation outweighs the negative implications of lower dividends, resulting in a mild positive overall market impact.
Legend:
🔴 = Strong Negative Impact 🔸 = Mild Negative Impact ⚪ = Neutral 🔹 = Mild Positive Impact 🔵 = Strong Positive Impact
SpaceX is targeting a valuation of at least $1.8 trillion in its initial public offering, according to sources, after Bloomberg News reported in April that SpaceX was aiming for a valuation above $2 trillion. Bloomberg's space and aviation managing editor Benedikt Kammel joined David Gura and Christina Ruffini on Bloomberg This Weekend to discuss....
Bloomberg Markets and Finance - 5/31/2026 11:50:36 AM
More News for TRCK
Stock Analysis for TRCK
Related Stocks:
The 2026 NBA Finals schedule is set....
Posting and Toasting - 5/31/2026 3:56:00 AM
More News for
Stock Analysis for
Related Stocks:
Frontrunner Cepeda has vowed to continue path of incumbent Petro who cut ties with Jewish state; right-wingers De La Espriella and Valencia want to restore alliance...
The Times of Israel - 5/31/2026 3:51:50 AM
More News for
Stock Analysis for
Related Stocks:
Protesters and the New Jersey State Police clashed outside the immigration detention center Saturday night, hours after Gov. Mikie Sherrill urged demonstrators to lower the temperature....
The New York Times - 5/31/2026 3:50:02 AM
More News for
Stock Analysis for
Related Stocks:
The Department of Homeland Security issued a statement Saturday saying recent green card policy changes restated "longstanding law and policy."...
CBS News - 5/31/2026 3:44:07 AM
More News for
Stock Analysis for
Related Stocks:
Jes Staley has agreed to be interviewed on July 23 by the House Oversight and Government Reform Committee about his late friend, the sex offender Jeffrey Epstein. Staley is a former top executive at JPMorgan Chase....
CNBC - 5/31/2026 11:53:27 AM
More News for BCS
Stock Analysis for BCS
Related Stocks:
Collateralized loan obligations (CLOs) are securitized portfolios of corporate loans divided into tranches by risk profile. For many retail investors, CLOs can be foreign and uncomfortable, but the potential for attractive yields, floating-rate income, and diversification is strong....
MarketBeat - 5/31/2026 11:51:16 AM
More News for CLOA
Stock Analysis for CLOA
Related Stocks:
Pfizer's stock has fallen more than 50% from its 2021 high. The stock is trading below its pre-coronavirus pandemic level....
The Motley Fool - 5/31/2026 11:15:00 AM
More News for PFE
Stock Analysis for PFE
Related Stocks:
Progyny delivers fertility benefits to major employers; a key insider recently trimmed their stake, according to SEC filings....
Fool - Investing News - 5/31/2026 11:02:49 AM
More News for PGNY
Stock Analysis for PGNY
Related Stocks:
These ultra-high-yielding dividend stocks have done a solid job delivering sustainable income streams....
Fool - Investing News - 5/31/2026 11:01:00 AM
More News for ARCC
Stock Analysis for ARCC
Related Stocks:
This humanoid robotics ETF (KOID) has been performing wonderfully, though it's only been in existence for about a year....
Fool - Investing News - 5/31/2026 11:00:00 AM
More News for NVDA
Stock Analysis for NVDA
Related Stocks:
The start of a new month provides the perfect opportunity to take a fresh look at your portfolio....
Fool - Investing News - 5/31/2026 10:47:00 AM
More News for VXUS
Stock Analysis for VXUS
Related Stocks:
Riley Exploration Permian (REPX) boasts highly profitable wells. REPX was already paying dividends, growing production, and reducing debt before the recent surge in oil prices. The stock trades at a low P/E ratio of 5, making it exceptionally cheap for a profitable U.S.-based operator....
Seeking Alpha - 5/31/2026 11:30:00 AM
More News for REPX
Stock Analysis for REPX
Related Stocks:
The nuclear power industry is undergoing a major resurgence that's built to last as long as AI data centers continue to proliferate. This company is well-positioned as the market leader in key geographic markets....
The Motley Fool - 5/31/2026 11:05:00 AM
More News for CCJ
Stock Analysis for CCJ
Related Stocks:
The quantum computing trade has shifted from a speculative bet to an identifiable, investable theme, and the three exchange-traded funds that best capture it each take a different angle on the same transition....
24/7 Wall Street - 5/31/2026 11:15:35 AM
More News for QMCO
Stock Analysis for QMCO
Related Stocks:
American Express differs from other credit card companies, and its model gives it a durable competitive edge. American Express stock has soundly beaten Visa and Mastercard, as well as the S&P 500, over the past five years....
The Motley Fool - 5/31/2026 10:52:00 AM
More News for V
Stock Analysis for V
Related Stocks:
This digital manufacturing platform, serving diverse industries, reported a notable insider sale amid strong one-year stock performance....
Fool - Investing News - 5/31/2026 10:24:03 AM
More News for XMTR
Stock Analysis for XMTR
Related Stocks:
Peloton, a leader in connected fitness and digital subscriptions, reported a notable insider sale amid ongoing market challenges....
Fool - Investing News - 5/31/2026 10:23:11 AM
More News for PTON
Stock Analysis for PTON
Related Stocks:
The legacy business is funding a shift to electric vehicles (EVs) and industrial power generation....
Fool - Investing News - 5/31/2026 10:22:00 AM
More News for BWA
Stock Analysis for BWA
Related Stocks:
This clinical-stage biotech focused on antibody therapies for immunological disorders reported a notable insider sale in its latest filing....
Fool - Investing News - 5/31/2026 10:21:54 AM
More News for ORKA
Stock Analysis for ORKA
Related Stocks:
This global pumping systems provider operates across key infrastructure markets; a recent insider sale highlights evolving ownership trends....
Fool - Investing News - 5/31/2026 10:20:30 AM
More News for FELE
Stock Analysis for FELE
Related Stocks:
Mineralys Therapeutics develops novel therapies for resistant hypertension, with its lead candidate advancing through clinical trials....
Fool - Investing News - 5/31/2026 10:19:50 AM
More News for AZN
Stock Analysis for AZN
Related Stocks:
Investor interest in the AI space continues to grow, with many focusing on AI infrastructure plays to meet the increasing demand for data centers or on semiconductor stocks building the components necessary for AI platforms to function. One potentially overlooked area that is vital to AI but not directly related to the technology itself is land....
MarketBeat - 5/31/2026 11:06:28 AM
More News for GRAB
Stock Analysis for GRAB
Related Stocks:
Donald Trump calls for Freedom 250 Concert to be canceled and suggests it is replaced by a MAGA rally following a mass exodus of scheduled performers....
Deadline - 5/31/2026 3:00:00 AM
More News for
Stock Analysis for
Related Stocks:
Despite pressures on the cruise industry because of geopolitics and the oil price shock, the Viking Holdings' stock continues to rise unabated. The company's double-digit percent revenue growth and expanding adjusted EBITDA in Q1 2026 work in its favour, even as there has been a seasonal net loss. A resolution to the war can support the company's fundamentals even more, though its stock price can see a short-term dip then as investors interest moves towards sector laggards....
Seeking Alpha - 5/31/2026 10:57:10 AM
More News for VIK
Stock Analysis for VIK
Related Stocks:
Ford (NYSE:F | F Price Prediction) and General Motors (NYSE:GM) closed Q1 2026 with a sharp contrast....
24/7 Wall Street - 5/31/2026 10:48:39 AM
More News for F
Stock Analysis for F
Related Stocks:
The 2026 NBA Finals are set....
Posting and Toasting - 5/31/2026 2:54:00 AM
More News for
Stock Analysis for
Related Stocks:
Once in the blue moon happens Saturday night....
KOMO - 5/31/2026 2:48:45 AM
More News for
Stock Analysis for
Related Stocks:
Comfort Systems USA rated BUY with a $2,150 12-month price target, leveraging a recent 14% correction as an attractive entry into a secular growth story. FIX's growth is underpinned by surging AI data center construction and US manufacturing reshoring, with technology clients now 56% of Q1 2026 revenues. Revenues surged 29.5% in 2025 and 56% YoY in Q1 2026, with gross margins expanding to 24.1% and a record $12.5Bn backlog driven by strong order intake....
Seeking Alpha - 5/31/2026 10:43:13 AM
More News for FIX
Stock Analysis for FIX
Related Stocks:
Inflation has a way of turning economics into personal finance. For retirees living on fixed incomes, every increase in the price of groceries, gasoline, utilities, and healthcare stretches a monthly Social Security check a little further than it was designed to go. And after years of inflation shocks, Americans are once again watching prices climb.... Trump and Kevin Warsh Plan a Huge Giveaway to Retirees. There's Only One Problem...
247 Wallst - 5/31/2026 10:43:28 AM
More News for
Stock Analysis for
Related Stocks:
New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of Immutep Ltd. (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026, inclusive (the "Class Period"), of the important July 6, 2026 lead plaintiff deadline....
Newsfile Corp - 5/31/2026 10:42:00 AM
More News for IMMP
Stock Analysis for IMMP
Related Stocks:
Picture a 67-year-old who cleaned hotel rooms in her 30s, ran a cash register through her 40s, and spent her 50s in a diner kitchen. Thirty years of steady work, almost none above $25,000 a year. Now she stares at her Social Security statement and wonders if that is really all the system has for... Social Security's Special Minimum Benefit is Disappearing. Here's Who Still Qualifies in 2026...
247 Wallst - 5/31/2026 10:40:35 AM
More News for
Stock Analysis for
Related Stocks:
AltaGas: Switch From Common Shares To Preferred Stock For A Strong 3-Year Return...
Seeking Alpha - 5/31/2026 10:40:00 AM
More News for AGEEF
Stock Analysis for AGEEF
Related Stocks:
SpaceX is seen by some as an amazing opportunity to benefit from what will be the largest IPO to date. I clearly do not share this optimism. Decades of experience in the securities industry lead me to prefer substance over hype. My opening paragraph shows my thesis as to why I am avoiding the hoopla surrounding the SpaceX IPO....
Seeking Alpha - 5/31/2026 10:39:54 AM
More News for P-SPAC
Stock Analysis for P-SPAC
Related Stocks:
A 68-year-old retired teacher in Ohio got her full Social Security check this spring after the Windfall Elimination Provision was repealed, only to watch a chunk of the raise vanish into a higher Medicare premium and a tax surprise. A retired couple in Arizona is trying to figure out whether the new senior bonus deduction... Social Security Retirees Face a New Tax Cliff in 2026. Most Americans Missed It...
247 Wallst - 5/31/2026 10:10:54 AM
More News for
Stock Analysis for
Related Stocks:
KALDVIK AS (KLDVK) reports Operating income in Q1 amounted to EURm 36. 5 (EURm 48. 4), while the operating loss before fair value adjustment of biomass and production tax was EURm -26. 4 (EURm 9. 8)....
Globe News Wire - 5/31/2026 10:04:40 AM
More News for
Stock Analysis for
Related Stocks:
Inflation may be one of the few issues capable of uniting Americans across party lines. Voters can argue endlessly about tax policy, government spending, tariffs, or regulation. But when the cost of groceries, gasoline, and housing starts climbing faster than paychecks, political loyalties often take a back seat to household budgets. That's because inflation isn't... Bidenflation Hit Harder, but Trumpflation May Last Longer...
247 Wallst - 5/31/2026 10:01:50 AM
More News for
Stock Analysis for
Related Stocks:
Meta Platforms (NASDAQ:META | META Price Prediction) just reported one of the strangest quarters in mega-cap tech....
24/7 Wall Street - 5/31/2026 10:38:37 AM
More News for META
Stock Analysis for META
Related Stocks:
Philadelphia, Pennsylvania--(Newsfile Corp. - May 31, 2026) - WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Zoetis, Inc. (NYSE: ZTS)....
Newsfile Corp - 5/31/2026 10:22:00 AM
More News for ZTS
Stock Analysis for ZTS
Related Stocks:
Alamos Gold (AGI) is a leveraged bet on gold, offering amplified returns relative to simply holding gold, through multiple expansion. At 0.88x NAV, the stock trades at a cheap valuation relative to its mine-by-mine intrinsic value, with an upside potential even before any re-rating. With management guiding declining AISC and growing production through 2028, the company presents meaningful earnings upside even if gold prices simply sustain at current levels....
Seeking Alpha - 5/31/2026 10:17:50 AM
More News for AGI
Stock Analysis for AGI
Related Stocks:
Released on Saturday, the final Emerson College Polling California survey before Tuesday’s primary election found that Becerra leads the race for governor with 28%. Tom Steyer and Steve Hilton follow closely behind....
Los Angeles Times - 5/31/2026 2:24:00 AM
More News for
Stock Analysis for
Related Stocks:
Developer IO Interactive is seeing unprecedented success with the debut of its new 007 video game....
Mashable - 5/31/2026 2:21:09 AM
More News for
Stock Analysis for
Related Stocks:
New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Elauwit Connection, Inc. (NASDAQ: ELWT) resulting from allegations that Elauwit may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Elauwit securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement....
Newsfile Corp - 5/31/2026 10:17:00 AM
More News for ELWT
Stock Analysis for ELWT
Related Stocks:
New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock on the New York Stock Exchange ("NYSE") of Stellantis N.V. (NYSE: STLA) between February 26, 2025 and February 5, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline....
Newsfile Corp - 5/31/2026 10:17:00 AM
More News for STLA
Stock Analysis for STLA
Related Stocks:
Artificial intelligence (AI) is the trade of the decade. It turned NVIDIA NASDAQ: NVDA into a household name....
MarketBeat - 5/31/2026 10:16:35 AM
More News for NVDA
Stock Analysis for NVDA
Related Stocks:
New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of POET Technologies Inc. (NASDAQ: POET) between April 1, 2026 and 08:57 AM ET on April 27, 2026, inclusive (the "Class Period"), of the important June 29, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased POET Technologies securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement....
Newsfile Corp - 5/31/2026 10:15:00 AM
More News for POETF
Stock Analysis for POETF
Related Stocks:
New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SES AI Corporation (NYSE: SES) between January 29, 2025 and March 4, 2026, both dates inclusive (the "Class Period"), of the important June 26, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased SES AI securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement....
Newsfile Corp - 5/31/2026 10:14:00 AM
More News for SGBAF
Stock Analysis for SGBAF
Related Stocks:
Verizon stands as the only Dow stock meeting the ideal of annual dividends from $1K invested exceeding its share price, supported by strong free cash flow. Analyst forecasts suggest top-ten Dow Dogs could deliver 17.15% to 45.09% net gains by June 2027, with an average estimated gain of 27.71%. Most Dow dividend stocks are currently overpriced, but market corrections or dividend increases could create more fair-priced buying opportunities....
Seeking Alpha - 5/31/2026 10:12:58 AM
More News for DOW
Stock Analysis for DOW
Related Stocks:
Booz Allen Chairman and CEO Horacio Rozanski joins 'Mornings with Maria' to discuss the risks Chinese AI models pose to U.S. national security, combating agentic AI threats, their partnership with Anduril and more. 00:00 The AI race between the US and China 01:05 Vulnerabilities in Chinese AI models 01:45 Risks to the software supply chain 03:52 2026: The year of Agentic AI 05:03 Booz Allen's role in National Security 06:01 Partnership with Anduril and drone production...
Fox Business - 5/31/2026 10:00:39 AM
More News for BAH
Stock Analysis for BAH
Related Stocks:
The last time inflation was this high, the S&P 500 was in a bear market....
Fool - Investing News - 5/31/2026 9:54:00 AM
More News for
Stock Analysis for
Related Stocks:
Nuclear power can benefit from the AI revolution. Two innovative nuclear stocks are positioned to benefit....
The Motley Fool - 5/31/2026 9:45:00 AM
More News for OKLO
Stock Analysis for OKLO
Related Stocks:
Jerome Powell's successor wants to lead a reform-oriented central bank, but this can prove disastrous for the stock market....
Fool - Investing News - 5/31/2026 9:06:00 AM
More News for
Stock Analysis for
Related Stocks:
You probably have different goals than Berkshire Hathaway....
Fool - Investing News - 5/31/2026 9:05:00 AM
More News for AMZN
Stock Analysis for AMZN
Related Stocks:
Kimbell is making a $147 million Permian Basin acquisition of mineral and royalty interests, with the consideration roughly 30% cash and 70% equity. It expects forward-year production of 1,390 BOEPD (54% oil) from those assets. This adds around 9% to its oil production. Kimbell's unit count is increasing by approximately 6% from the deal, and its distributable cash flow may increase by around 1% per unit....
Seeking Alpha - 5/31/2026 10:03:32 AM
More News for PGPHF
Stock Analysis for PGPHF
Related Stocks:
Canadian Solar is rated Buy, driven by a booming e-STORAGE business with a record $3.5B contracted backlog. CSIQ's e-STORAGE revenue is set to accelerate, with shipment guidance raised to 4.5–5.5 GWh in FY2026 and strong growth projected through 2027. Consensus expects CSIQ to return to profitability in FY2027, with EPS reaching $0.98 and revenue growth of 25.76% YoY....
Seeking Alpha - 5/31/2026 10:02:36 AM
More News for CSIQ
Stock Analysis for CSIQ
Related Stocks:
The remains of all missing victims in a Washington state paper mill explosion have been recovered, officials announced Saturday.“Today, on day five of this incident, I can share that we have recovered the ninth and final missing employee of this incident,” Longview Fire Chief Brad Hannig said in a Saturday news conference....
NBC News - 5/31/2026 2:03:00 AM
More News for
Stock Analysis for
Related Stocks:
Its backlog has grown to over $2 billion as it positions itself as an end-to-end space company. The company's revenue is steadily climbing and reached $200 million in this year's first quarter....
The Motley Fool - 5/31/2026 9:30:00 AM
More News for RKLB
Stock Analysis for RKLB
Related Stocks:
Memo on US president's health released after physical earlier in the week; leg swelling continues but has improved, memo says; Trump turns 80 in June...
The Times of Israel - 5/31/2026 1:55:32 AM
More News for
Stock Analysis for
Related Stocks:
Summer is often a slow time on Wall Street, as investors take time off for family and vacations. If you are planning some summer fun, here's a simple formula for generating dividends that requires little attention....
The Motley Fool - 5/31/2026 9:15:00 AM
More News for DIVO
Stock Analysis for DIVO
Related Stocks:
RYBREVANT FASPRO⢠(amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where...
GuruFocus - 5/31/2026 9:00:00 AM
More News for JNJ
Stock Analysis for JNJ
Related Stocks:
GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri Test Substantially Increased Cancer Detection With R...
GuruFocus - 5/31/2026 9:00:00 AM
More News for GRAL
Stock Analysis for GRAL
Related Stocks:
Johnson and Johnson's Phase 3 prostate cancer study shows ERLEADAÂ (apalutamide) before and after surgery significantly reduces risk of metastas...
GuruFocus - 5/31/2026 9:00:00 AM
More News for APA
Stock Analysis for APA
Related Stocks:
Welcome to The Muni Brief, a series on municipal credit and markets. In each installment, Senior Municipal Strategist James Colby examines current events, policy developments, and fiscal trends through the lens of the muni investor — covering topics both local and national....
ETF Trends - 5/31/2026 9:36:59 AM
More News for NYC
Stock Analysis for NYC
Related Stocks:
A Love Island USA cast member has been dismissed from the reality dating show just days ahead of its eighth season premiere following resurfaced videos in which the contestant used a racial slur. Vasa......
Yahoo - 5/31/2026 12:22:00 AM
More News for
Stock Analysis for
Related Stocks:
Silicom Ltd. is rated buy, trading at a steep 2.36x NTM revenue versus a 9.51x peer median, despite five quarters of sequential growth. SILC's design-win model, R&D intensity, and expanding edge/security use cases drive recurring revenue and create structural switching costs. Three macro tailwinds—AI inference, post-quantum cryptography, and white-label switches—support a bottom-line recovery and offer material upside optionality....
Seeking Alpha - 5/31/2026 9:25:55 AM
More News for SILC
Stock Analysis for SILC
Related Stocks:
The president had earlier said on social media that he should take the place of “these highly paid, Third Rate ‘Artists,’” saying he gets “larger audiences than Elvis.”...
The New York Times - 5/31/2026 1:14:45 AM
More News for
Stock Analysis for
Related Stocks:
Repligen Has A Cleaner Recovery Angle, But With High Valuation...
Seeking Alpha - 5/31/2026 9:15:00 AM
More News for RGEN
Stock Analysis for RGEN
Related Stocks:
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) today announced positive overall survival (OS) results from the Phase III HARMONi-6 trial, conducted in China and sponsored by Summit's partner Akeso, Inc. (HKEX Code: 9926.HK), will be presented today as part of the Plenary Session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. The presentation is entitled “Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in previously untrea....
Business Wire - 5/31/2026 9:06:00 AM
More News for SMMT
Stock Analysis for SMMT
Related Stocks:
IMA401 achieved deep and durable responses in various indications, including melanoma and head and neck cancer, with an initial promising clinical signal observed in lung cancer In head and neck cancer, IMA401 treatment at recommended Phase 2 dose (RP2D) with or without pembrolizumab resulted in a 29% confirmed ORR (4/14), 64% DCR (9/14) and mDOR of 8....
Globe News Wire - 5/31/2026 9:00:00 AM
More News for IMTX
Stock Analysis for IMTX
Related Stocks:
The Moment Many Retirees Don't See Coming A 70-year-old living on $30,000 in Social Security has been getting by on a tight budget for years. The car needs replacing, the roof is leaking, and the traditional IRA has been sitting there untouched. Pulling out $50,000 to cover the year's big expenses feels reasonable. Then the... The Hidden Cost of Large IRA Withdrawals: How $50,000 Can Cost You $6,200 in Taxes...
247 Wallst - 5/31/2026 8:45:27 AM
More News for
Stock Analysis for
Related Stocks:
The SpaceX IPO is putting the focus on the massive opportunity in space, and these two stocks stand to benefit....
Fool - Investing News - 5/31/2026 8:45:00 AM
More News for ASTS
Stock Analysis for ASTS
Related Stocks:
New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of New Era Energy & Digital, Inc. (NASDAQ: NUAI) between November 6, 2024 and December 29, 2025, inclusive (the "Class Period"), of the important June 1, 2026 lead plaintiff deadline. SO WHAT: If you purchased New Era Energy securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement....
Newsfile Corp - 5/31/2026 9:11:00 AM
More News for NUAI
Stock Analysis for NUAI
Related Stocks:
ePlus inc. ended FY2026 on a strong note. Fourth quarter revenues grew well, which ePlus managed to turn into increased earnings. AI seems to be a tailwind on PLUS's growth going forward, as customers are investing in AI capabilities. There's reason to be cautious. PLUS's FY2026 growth seems to have been achieved due to a few outsized projects, which may not be replicated....
Seeking Alpha - 5/31/2026 9:08:22 AM
More News for PLUS
Stock Analysis for PLUS
Related Stocks:
Vicor: Mid-Quarter Guidance Raise Confirms The IP Thesis (Rating Upgrade)...
Seeking Alpha - 5/31/2026 9:06:00 AM
More News for VICR
Stock Analysis for VICR
Related Stocks:
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Immutep To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Immutep between March 24, 2025 and March 12, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - May 31, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Immutep Limited ("Immutep" or the "Company") (NASDAQ: IMMP) and reminds investors of the July 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company....
Newsfile Corp - 5/31/2026 9:04:00 AM
More News for IMMP
Stock Analysis for IMMP
Related Stocks:
Amplify CWP Growth & Income ETF delivers a double-digit yield and equity appreciation, outperforming SPY since inception with a 44.68% total return. QDVO's tactical covered call strategy on a concentrated large-cap growth portfolio enables participation in rallies while generating recurring income. Technology exposure exceeds 40%, with the Magnificent Seven comprising 64% of assets, targeting both high option premiums and growth....
Seeking Alpha - 5/31/2026 9:00:00 AM
More News for QDVO
Stock Analysis for QDVO
Related Stocks:
A loud noise caused by a meteor was heard throughout Rhode Island and Massachusetts at around 2:10 on Saturday afternoon....
WJAR - 5/31/2026 12:56:17 AM
More News for
Stock Analysis for
Related Stocks:
Microsoft offers significant upside, with robust growth drivers from AI partnerships and cloud expansion, making current valuations highly attractive. Partnership with Anthropic could generate up to $43 billion in annual revenue by 2030, boosting MSFT's AI and cloud prospects. Accelerated AI data center deployment and Copilot's shift to usage-based pricing are set to drive recurring revenue and margin expansion for MSFT....
Seeking Alpha - 5/31/2026 9:00:00 AM
More News for MSFT
Stock Analysis for MSFT
Related Stocks:
BitFuFu is downgraded to Hold after Q1 FY26 results reveal persistent tight margins. FUFU's dual-engine model hedges revenue volatility, with cloud mining now 79% of revenue, but cost structure remains burdened by related-party hosting fees. Operational efficiency improved: hashrate under management rose 25.7% YoY while power capacity fell, yet gross margin stayed minimal at 0.51%....
Seeking Alpha - 5/31/2026 9:00:00 AM
More News for FUFU
Stock Analysis for FUFU
Related Stocks:
Intellia Therapeutics remains a Buy, driven by two pivotal in vivo gene therapy catalysts: Lonvo-Z for HAE and Nex-Z for ATTR amyloidosis. Lonvo-Z's Phase 3 data met all endpoints with an 87% attack reduction, but market reaction was muted due to safety concerns and the competitive landscape. The FDA lifted clinical holds on Nex-Z Phase 3 trials, enabling advancement in a $16.8bn ATTR market with a differentiated one-time treatment profile....
Seeking Alpha - 5/31/2026 8:45:00 AM
More News for NTLA
Stock Analysis for NTLA
Related Stocks:
The iShares Core S&P U.S. Value ETF offers broad, diversified exposure to U.S. value equities with a low 0.04% expense ratio. IUSV's long-term returns and volatility closely match the Russell 1000 benchmark, but recent performance lags, with a 6% shortfall over the past year. Competitors VLUE and FVAL have outperformed IUSV since 2016, aided by cash-flow-based valuation and sector-specific methodologies....
Seeking Alpha - 5/31/2026 8:37:59 AM
More News for IUSV
Stock Analysis for IUSV
Related Stocks:
Believe it or not, June is here, and with it the summer trading season. That means lower trading volumes, potential for volatility, and opportunities for savvy traders....
MarketBeat - 5/31/2026 8:36:20 AM
More News for AIRJ
Stock Analysis for AIRJ
Related Stocks:
New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of DNOW Inc. (NYSE: DNOW) resulting from allegations that DNOW may have issued materially misleading business information to the investing public. SO WHAT: If you purchased DNOW securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement....
Newsfile Corp - 5/31/2026 8:32:00 AM
More News for DNOW
Stock Analysis for DNOW
Related Stocks:
Hormel Foods Corporation reported positive Q2 results. Input cost inflation has weighed on HRL's margins, but retail segment earnings are finally stabilized in the report. A stabilizing earnings outlook makes HRL's dividend yield safer and more attractive....
Seeking Alpha - 5/31/2026 8:30:00 AM
More News for HRL
Stock Analysis for HRL
Related Stocks:
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of the next-generation of Lens, its pioneering agentic AI platform designed to accelerate drug development and research. This evolution seamlessly connects Tempus' multimodal data, AI tooling and computational infrastructure to deliver actionable insights at the pace required for drug development. The next-generation of the Lens platf....
Business Wire - 5/31/2026 8:30:00 AM
More News for TEM
Stock Analysis for TEM
Related Stocks:
Japan's Softbank is planning to invest 45 billion euros ($53 billion) over five years to build AI infrastructure in France in the first phase of its push. The commitment is part of a 75-billion-euro ($87 billion) program by Softbank to build AI data centers in France...
CNBC - 5/31/2026 8:09:54 AM
More News for SOBKY
Stock Analysis for SOBKY
Related Stocks:
Sandisk and Micron are both memory chip producers. Both companies are seeing rapid growth....
The Motley Fool - 5/31/2026 8:08:00 AM
More News for MU
Stock Analysis for MU
Related Stocks:
The wife of Maine Democratic Senate candidate Graham Platner said she was “deeply hurt” after details of her husband’s extramarital sexting became public Saturday, accusing a former campaign official and confidante of betraying her trust....
CNN - 5/31/2026 12:28:00 AM
More News for
Stock Analysis for
Related Stocks:
The S&P 500 dividend yield has fallen to 1.08%, a level the index has not seen since the 1800s....
24/7 Wall Street - 5/31/2026 8:26:47 AM
More News for SPY
Stock Analysis for SPY
Related Stocks:
Officials in Longview, Washington, said Saturday afternoon that all nine workers who were missing after a white liquor tank implosion at a paper mill....
KATU - 5/31/2026 12:11:03 AM
More News for
Stock Analysis for
Related Stocks:
My parents have one credit card
and they only use it for one thing. Here's what that's cost them, and the one additional card that could save them a ton....
Fool - Investing News - 5/31/2026 8:05:03 AM
More News for
Stock Analysis for
Related Stocks:
Your age affects how much you have saved for retirement. See where you stand relative to the typical Gen Xer....
Fool - Investing News - 5/31/2026 7:50:00 AM
More News for
Stock Analysis for
Related Stocks:
The S&P 500 is up nearly 10% year to date....
Fool - Investing News - 5/31/2026 7:44:00 AM
More News for
Stock Analysis for
Related Stocks:
That slump won't be instantly reversed, but SoundHound AI still has long-term potential....
Fool - Investing News - 5/31/2026 7:33:00 AM
More News for SOUN
Stock Analysis for SOUN
Related Stocks:
An experimental drug developed by China-based Akeso helped patients with advanced squamous non-small cell lung cancer live 15% longer than BeOne Medicines' immunotherapy Tevimbra, and cut the risk of death by more than one-third in a study presented at a medical meeting on Sunday....
Reuters - 5/31/2026 8:03:54 AM
More News for AKESF
Stock Analysis for AKESF
Related Stocks:
Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six months before and after prostate surgery improved the chances of eliminating the cancer and reduced the risk of disease progression or death, according to data from a late-stage trial presented on Sunday....
Reuters - 5/31/2026 8:01:58 AM
More News for JNJ
Stock Analysis for JNJ
Related Stocks:
Poland has become one of Europe's standout growth stories, with an economy that crossed $1 trillion and a new generation of entrepreneurs returning home after studying and working abroad. Finance Minister Andrzej Domański points to decades of reform, EU integration, foreign investment and a diversified economy as drivers of Poland's rise, while venture capitalist Aleksandra Pedraszewska says Warsaw's technology scene now offers opportunities that were far less obvious a decade ago....
Bloomberg Markets and Finance - 5/31/2026 8:00:12 AM
More News for EPOL
Stock Analysis for EPOL
Related Stocks:
The governor said most of those arrested in a weekend clash were from outside New Jersey....
Gothamist - 5/31/2026 12:03:00 AM
More News for
Stock Analysis for
Related Stocks:
An experimental lung cancer drug from Akeso and Summit Therapeutics improved survival in the Harmoni-6 Phase 3 trial conducted in China, according to results being presented at the American Society of Clinical Oncology annual meeting. Called ivonescimab, the bispecific antibody targets PD-1 — similar to Merck's best-selling drug Keytruda — and VEGF — similar to Roche's Avastin....
CNBC - 5/31/2026 8:00:02 AM
More News for SMMT
Stock Analysis for SMMT
Related Stocks:
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced detailed progression-free and overall survival results from Cohort 3, a randomized cohort of the Phase 3 BREAKWATER trial, evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and FOLFIRI (fluorouracil, leucovorin, and irinotecan) versus FOLFIRI with or without bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) with a BRAF V600E mutation. These results will be....
Business Wire - 5/31/2026 8:00:00 AM
More News for PFE
Stock Analysis for PFE
Related Stocks:
